Concepedia

Author

Anis K. Mir

Novartis (Switzerland)

Also Known As

A MIR, A Mir, A. K. Mir, A. Mir, A.K. MIR, A.K. Mir, Aadil Ahmed Mir, Abid Imtiyaz Mir, Ahmed Jahangir Mir, Anis K Mir

106

Publications

6K

Citations

41

H-Index

123

Concepts

All Affiliations

Novartis (Switzerland)Novartis Institutes for BioMedical ResearchUniversity of ZurichETH ZurichUniversity of Fribourg
AK

About

Anis K. Mir is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and neuroscience.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

27

40

2.8K

2

Social Sciences

8

8

469

3

Health Sciences

6

6

435

4

Natural Sciences

6

6

420

5

Engineering

2

2

40

Anis K. Mir

×

67

Publications

5.4K

Citations

38

H-Index

YearCitations

Nogo‐A antibody improves regeneration and locomotion of spinal cord–injured rats

Thomas Liebscher, Lisa Schnell, Dina Schnell,

Annals of Neurology

2005

349

Nogo-A–specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates

Patrick Freund, Eric Schmidlin, Thierry Wannier,

Nature Medicine

2006

333

Monocyte Chemoattractant Protein-1 Deficiency is Protective in a Murine Stroke Model

P. Hughes, Peter R. Allegrini, Markus Rudin,

Journal of Cerebral Blood Flow & Metabolism

2002

295

Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS

P. Hughes, Michelle Sandra Botham, Stefan Frentzel,

Glia

2002

248

Cardiovascular Response to 8-Hydroxy-2-(di-n-Propylamino) Tetralin (8-OH-DPAT) in the Rat: Site of Action and Pharmacological Analysis

John R. Fozard, Anis K. Mir, Derek N. Middlemiss

Journal of Cardiovascular Pharmacology

1987

211

Anti—Nogo-A Antibody Infusion 24 Hours after Experimental Stroke Improved Behavioral Outcome and Corticospinal Plasticity in Normotensive and Spontaneously Hypertensive Rats

Florence M. Bareyre, Peter R. Allegrini, Anis K. Mir,

Journal of Cerebral Blood Flow & Metabolism

2003

205

First-in-Man Intrathecal Application of Neurite Growth-Promoting Anti-Nogo-A Antibodies in Acute Spinal Cord Injury

Klaus Kucher, Donald R. Johns, Doris Maier,

Neurorehabilitation and neural repair

2018

202

The Second-Generation Active A  Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects

Karl‐Heinz Wiederhold, Alain C. Tissot, Pascal Frey,

Journal of Neuroscience

2011

190

Neutralization of interleukin‐1β modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice

Fredrik Clausen, Anders Hånell, Maria Björk,

European Journal of Neuroscience

2009

188

ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157

Dominik Feuerbach, Patrick Schindler, Carmen Barske,

Neuroscience Letters

2017

179

Page 1